VICTORY CAPITAL MANAGEMENT INC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$260,459
-21.0%
7,306
+2.2%
0.00%
Q2 2023$329,830
+12.4%
7,150
-2.3%
0.00%
Q1 2023$293,412
-14.3%
7,317
-1.0%
0.00%
Q4 2022$342,471
+11.9%
7,392
-0.0%
0.00%
Q3 2022$306,000
-31.4%
7,395
-1.0%
0.00%
-100.0%
Q2 2022$446,000
-15.4%
7,468
+0.1%
0.00%0.0%
Q1 2022$527,000
-15.7%
7,459
+0.3%
0.00%0.0%
Q4 2021$625,000
+4.7%
7,438
+12.4%
0.00%0.0%
Q3 2021$597,000
+1.5%
6,615
+7.3%
0.00%0.0%
Q2 2021$588,000
-19.6%
6,167
-3.9%
0.00%0.0%
Q1 2021$731,000
-21.9%
6,417
-5.1%
0.00%0.0%
Q4 2020$936,000
+141.2%
6,760
+43.2%
0.00%
Q3 2020$388,000
-1.3%
4,720
-6.1%
0.00%
-100.0%
Q2 2020$393,000
-16.7%
5,024
-52.7%
0.00%
Q1 2020$472,000
+49.4%
10,630
+43.6%
0.00%
Q4 2019$316,000
+17.0%
7,400
+17.2%
0.00%
Q3 2019$270,000
+592.3%
6,313
+1137.8%
0.00%
Q3 2018$39,000
+14.7%
510
+15.1%
0.00%
Q2 2018$34,000
+47.8%
4430.0%0.00%
Q1 2018$23,000
+9.5%
4430.0%0.00%
Q4 2017$21,000
-12.5%
4430.0%0.00%
Q3 2017$24,000
-14.3%
4430.0%0.00%
Q2 2017$28,000
+3.7%
443
+10.8%
0.00%
Q1 2017$27,000
+17.4%
400
+24.2%
0.00%
Q4 2016$23,000
+9.5%
322
+9.5%
0.00%
Q3 2016$21,0002940.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2021
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$5,084,0002.52%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,237,825$83,900,0001.18%
CAPITAL INTERNATIONAL LTD /CA/ 206,718$14,011,0000.91%
Cormorant Asset Management, LP 75,000$5,084,0000.74%
Capital International Sarl 107,450$7,283,0000.63%
Rock Springs Capital Management LP 159,750$10,828,0000.62%
Opus Point Partners Management, LLC 12,201$827,0000.61%
Hood River Capital Management LLC 109,629$7,431,0000.56%
Aureus Asset Management, LLC 50,740$2,927,0000.51%
ROCKEFELLER FINANCIAL SERVICES INC 374,663$25,395,0000.51%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders